Kathleen C. Flanders

Statistics

Publications

129

Citations

17.8K

H-Index

Active since

1982

Affiliations

National Cancer Institute(Current)

National Institutes of Health

Wakayama Medical University

Osaka City University

University of Cincinnati

Kathleen C. Flanders is an author at National Cancer Institute specializing in life sciences, transforming growth factor-beta signaling, and signal transduction.

Publications per year

1982–2019

129

Publications

129

Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death.

A B Kulkarni, C G Huh, Daniel M. Becker et al. · Proceedings of the National Academy of Sciences · 1993 · 2K citations

Life Sciences, Immunology, Pathology +16

Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells

Cornelius Knabbe, Marc E. Lippman, Lalage M. Wakefield et al. · Cell · 1987 · 982 citations

Life Sciences, Cell Biology, Oncology +12

Role of transforming growth factor-beta in the development of the mouse embryo.

Ursula Heine, E. F. Munoz, Kathleen C. Flanders et al. · The Journal of Cell Biology · 1987 · 751 citations · Full text

Life Sciences, Cell Biology, Developmental Biology +16

Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells.

Ellen Van Obberghen‐Schilling, N S Roche, Kathleen C. Flanders et al. · Journal of Biological Chemistry · 1988 · 603 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +7

Osteoblasts synthesize and respond to transforming growth factor-type beta (TGF-beta) in vitro.

Pamela Gehron Robey, Marian F. Young, Kathleen C. Flanders et al. · The Journal of Cell Biology · 1987 · 558 citations · Full text

Medicine, Developmental Biology, Bone Metabolism +15

1–5 of 129